Tallahassee, FL, United States of America

Nazarius Saah Lamango

USPTO Granted Patents = 4 

Average Co-Inventor Count = 1.1

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2002-2013

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations in Cancer Diagnosis by Nazarius Saah Lamango

Introduction

Nazarius Saah Lamango is a notable inventor based in Tallahassee, FL (US). He has made significant contributions to the field of cancer diagnosis and treatment, holding a total of four patents. His work focuses on innovative methods that enhance the understanding and management of cancer.

Latest Patents

Lamango's latest patents include groundbreaking methods for cancer diagnosis by measuring polyisoprenylated methylated protein methyl esterase activity. These methods aim to improve cancer diagnosis, facilitate decisions on appropriate cancer treatment, and raise awareness of predispositions to cancer. Additionally, his patents address potential cancer prevention and the monitoring of cancer therapy through the measurement of PMPMEase activity. Another significant patent focuses on the diagnosis and treatment of triple-negative breast cancer, utilizing the same measurement techniques.

Career Highlights

Throughout his career, Lamango has worked with esteemed institutions, including Florida Agricultural and Mechanical University. His research and innovations have contributed to advancements in cancer treatment methodologies, showcasing his dedication to improving patient outcomes.

Collaborations

Lamango has collaborated with various professionals in his field, including Clivel G Charlton, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Nazarius Saah Lamango's contributions to cancer diagnosis and treatment through his innovative patents highlight his commitment to advancing medical science. His work continues to pave the way for improved cancer management strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…